Enovis Corp - Company Profile

Powered by

All the sales intelligence you need on Enovis Corp in one solution.

$395 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Enovis Corp fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Enovis Corp.

Back to companies

Enovis Corp: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Related keylists

Enovis Corp (Enovis), formerly Colfax Corp, is a medical technology company that provides products and services for musculoskeletal health, joint reconstruction, vascular health, and pain management. The company is also focused on developing clinically differentiated solutions. Its portfolio of products includes rigid and soft orthopedic bracing, hot and cold therapy, therapeutic shoes and inserts, bone growth stimulators, vascular therapy systems, and other metals and metal alloys. The company serves commercial and governmental customers in the US and other countries. It has manufacturing, assembling, warehousing, and engineering facilities in Europe, Asia, South America, and the Middle East. Enovis is headquartered in Wilmington, Delaware, the US.

 Gain a 360-degree view of Enovis Corp and make more informed decisions for your business Gain a 360-degree view of Enovis Corp and make more informed decisions for your business Learn more
Headquarters United States of America
Address 2711 Centerville Road, Suite 400, Wilmington, Delaware, 19808
Website www.enovis.com
Telephone 1 302 2529160
No of Employees 7,802
Industry Medical Equipment
Ticker Symbol & Exchange ENOV (NYSE)
Revenue (2024) $2.2B 6.7% (2024 vs 2023)
EPS XYZ
Net Income (2024) XYZ -43.5% (2024 vs 2023)
Market Cap* $1.4B
Net Profit Margin (2024) XYZ -34.5% (2024 vs 2023)
* As of and is in US$
View Enovis Corp financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

Enovis Corp premium industry data and analytics

130+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

11+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Enovis Corp’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Services Brands
Bracing and Supports: Rehabilitation DJO
Ligament Bracing Aftermarket Service Enovis
Cloud Connected Bracing Bone Growth Stimulation Creating Better Together
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Enovis Corp portfolio and identify potential areas for collaboration Understand Enovis Corp portfolio and identify potential areas for collaboration Learn more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2025 Divestiture In October, the company sold its Dr. Comfort diabetic shoe business to Promus Equity Partners for US$60 million.
2025 New Products/Services In January, the company introduced Enovis Medical Education.
2024 Contracts/Agreements In October, the company entered into a partnership with Ossium Health to distribute OssiGraft and OssiGraft Prime cryopreserved viable bone matrix allografts through Enovis’ sales network.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Learn more
Image for loader

Competitor Comparison

Key Parameters Enovis Corp Stryker Corp DePuy Synthes Inc Zimmer Biomet Holdings Inc Embla Medical hf
Headquarters United States of America United States of America United States of America United States of America Iceland
City Wilmington Portage Warsaw Warsaw Reykjavik
State/Province Delaware Michigan Indiana Indiana -
No. of Employees 7,802 56,000 - 17,000 4,192
Entity Type Public Public Private Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Learn more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Learn more
Executives
Name Position Board Since Age
Damien McDonald Director; Chief Executive Officer Executive Board 2025 61
Sharon Wienbar Chair Executive Board 2016 64
Phillip B. Berry Chief Financial Officer; Senior Vice President Senior Management 2023 47
Bradley J. Tandy Chief Legal Officer; Senior Vice President Senior Management 2019 67
Oliver Engert Chief Administrative Officer Senior Management 2026 61
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Enovis Corp key executives to enhance your sales strategy Gain insight into Enovis Corp key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?